Kimberley Koetsier finished her medical degree at the Leiden University in 2018, for which she also spent six months working at Harborview Medical Center in Seattle, USA. She is currently working as a researcher at the Otorhinolaryngology and Radiation Oncology departments of the Leiden University Medical Center (LUMC). Her daily research focusses on (proton) radiation therapy for vestibular schwannomas, for which she has done a research rotation at the Massachusetts General Hospital in Boston, USA. In addition, she has developed a dedicated interest for patients suffering of Neurofibromatosis Type 2. She has assisted with the initiation of the NF2 clinic at the LUMC and she is a member of the patient-reported outcomes group of the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration. She is part of the local organizing committee of the scientific and public part of this year’s European NF meeting. Since NF2 is such a rare disease, she is putting dedicated effort in making the public day available for as many people as possible across the world.